Results 161 to 170 of about 23,951 (282)

Multiday Use of Non-Tunneled Central Venous Catheters in Vetted Adult Outpatients Undergoing Apheresis Collections of Autologous Peripheral Blood Stem Cells Is Feasible and Well Tolerated. [PDF]

J Clin Apher
Mindiola Romero AE, Griggs JR, Rollins-Raval MA, Fero ML, Raval JS.   +4 more
europepmc   +1 more source

Impact of blinatumomab and inotuzumab exposure on apheresis composition for CAR T in patients with B-cell acute lymphoblastic leukemia. [PDF]

Cytotherapy
Cantilena A, Han KL, Cai Y, Yates B, Jin P, Shah NN, Stroncek D, Dreyzin A.   +7 more
europepmc   +1 more source

Selective removal of soluble FLT-1 using a high-affinity DNA aptamer for potential apheresis treatment of preeclampsia. [PDF]

Sci Rep
Owari K, Piao H, Hori M, Futami K.
europepmc   +1 more source

Apremilast in Japanese patients with palmoplantar pustulosis: A randomized, Phase 3 trial

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 6, Page 994-1004, June 2026.
In this Phase 3 trial of Japanese patients with moderate to severe PPP (NCT05174065), significantly more patients achieved PPPASI‐50 at Week 16 with apremilast versus placebo. Patient‐reported outcomes, including pruritus and pain/discomfort, also showed significantly greater decreases at Week 16 with apremilast versus placebo.
Tadashi Terui, Yukari Okubo, Satomi Kobayashi, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Bruce Strober, Melinda Gooderham, Wendy Zhang, Junichiro Shimauchi, Masafumi Yaguchi, Takeshi Kimura, Ryuichi Ogawa, Hamid Amouzadeh, Masamoto Murakami   +15 more
wiley   +1 more source

Characteristics of older age apheresis platelet donors and analysis of pre-donation blood routine parameters: A 6-year retrospective cohort study in Jinan. [PDF]

Medicine (Baltimore)
Shi L, Li Y, Geng X, Ma L, Li X.
europepmc   +1 more source

Hepatitis E virus screening in Irish blood donors: Seven years of individual donation nucleic acid testing reveals a frequent blood donor infection—but what is the risk?

Transfusion Medicine, Volume 36, Issue 3, Page 279-289, June 2026.
Abstract Background Screening blood donations for HEV RNA mitigates the risk of transfusion‐transmitted HEV infection (TT‐HEV), a recognised blood safety issue in Europe. This study reports the findings of government‐funded HEV RNA blood donation screening 2016–2022 and includes an estimate of residual risk. Method Donation samples were universally and
Niamh O'Flaherty, Marice Mullarkey, Lisa Burke, Pádraig Williams, Jonathan Dean, Jola Szulc, Allison Waters   +6 more
wiley   +1 more source

Fibrinogen Apheresis and peripheral vascular disease: Some progress? [PDF]

, 2007
Schiffl, Helmut
core   +1 more source

Donor retention and return patterns in Saudi Arabia: Implications for blood safety and supply stability

Transfusion Medicine, Volume 36, Issue 3, Page 222-230, June 2026.
Abstract Background Sustaining a safe and sufficient blood supply requires not only recruiting first‐time donors but also retaining them over time. In Saudi Arabia, donor retention remains poorly understood, with limited data on return behavior, demographic influences, and temporal trends.
Wajnat A. Tounsi, Bushra S. Almalki
wiley   +1 more source

What is the best approach to blood transfusion in sickle cell disease? A scientometric analysis and literature review

Transfusion Medicine, Volume 36, Issue 3, Page 211-221, June 2026.
Abstract Background Blood transfusion remains a cornerstone in the management of sickle cell disease (SCD); however, it is frequently complicated by red cell alloimmunisation. A significant debate persists within the scientific community regarding the optimal strategy to mitigate this risk: the traditional, pragmatic approach of serologic phenotyping ...
Christiane Ruffato Carminati, Lucas Fernandes Ananias, Saulo Fernando Moreira da Silva, Anna Cecília Dias Maciel Carneiro, Helio Moraes de Souza, Sarah Cristina Sato Vaz Tanaka, Fernanda Bernadelli De Vito   +6 more
wiley   +1 more source

Is time to plasma exchange the right question in suspected thrombotic thrombocytopenic purpura? [PDF]

Hematol Transfus Cell Ther
Sinha RR.
europepmc   +1 more source